PRTA
PROTHENA CORP PUBLIC LTD COPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 7 ▲ Prothena reported a transformative Q1 2026: net income of $32.7M (di…
- May 22 ▲ 1 insider buy $981.3K at $9.81
- Jun 2 to Jun 16 ▲ 4 days of insider buys: $2.1M by 1 insider, avg $8.64
- Jul 29 ▼ 2 insiders sell $136.0K at $8.47
- Aug 7 ▲ 1 insider buy $323.2K at $8.62
- Aug 20 ▲ 1 insider buy $439.4K at $8.79
- Sep 2 ▲ 1 insider buy $255.7K at $9.47
- Sep 18 ▲ 1 insider buy $843.5K at $8.43
- Sep 28 to Oct 14 ▲ 7 days of insider buys: $5.9M by 1 insider, avg $8.54
- Oct 22 to Oct 23 ▲ 2 days of insider buys: $1.2M by 1 insider, avg $8.15
- Nov 5 ▼ Earnings: PRTA Q3 2026 Earnings: EPS $-0.32 (-48.4% vs est)
- Nov 9 ▲ 1 insider buy $1.2M at $8.53
Signal stack
Where each data set points today.
- InsidersBULLISH
1 insider bought $13.3M at an average $8.62. 2 insiders sold $136.0K. Price is 8% below their cost.
- InstitutionsBULLISH
Q3 2026: 17 added (0 new), 10 trimmed or exited.
- EstimatesFALLING
Current-quarter EPS estimate $0.740 → $0.525 over 90 days. 1 up, 0 down in 30 days.
- Short sellersSTEADY
Short interest −0.4% to 7.91M shares. 15.7 days to cover, ≈15.4% of shares.
- TrendDOWNTREND
6% below its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 8.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| MORGAN STANLEY | TRIM | $5.2M |
| Qube Research & Technologies Ltd | TRIM | $3.9M |
| Quantinno Capital Management LP | ADD | $1.7M |
| BNP PARIBAS FINANCIAL MARKETS | TRIM | $1.3M |
| Creative Planning | DOUBLED | $1.3M |
| Nuveen, LLC | NEAR_EXIT | $867.3K |
| Invesco Ltd. | ADD | $755.1K |
| BARCLAYS PLC | ADD | $536.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action May 2026Price is below the lowest target. Median implies +151%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| May 8, 2026 | Citizens MAINTAIN | Market Outperform |
| Feb 20, 2026 | RBC Capital MAINTAIN | Sector Perform |
| Dec 1, 2025 | Citizens MAINTAIN | Market Outperform |
| Nov 7, 2025 | HC Wainwright & Co. MAINTAIN | Buy |
| Nov 7, 2025 | RBC Capital MAINTAIN | Sector Perform |
| Oct 28, 2025 | Piper Sandler MAINTAIN | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
SCULLY WILLIAM P 10%+ Owner Nov 9, 2026 | BUY | $1.2M |
SCULLY WILLIAM P 10%+ Owner Nov 6, 2026 | GIFT | 916,444 sh |
SCULLY WILLIAM P 10%+ Owner Oct 27, 2026 | GIFT | 566,444 sh |
SCULLY WILLIAM P 10%+ Owner Oct 23, 2026 | BUY | $403.5K |
SCULLY WILLIAM P 10%+ Owner Oct 22, 2026 | BUY | $818.5K |
SCULLY WILLIAM P 10%+ Owner Oct 14, 2026 | BUY | $84.6K |
SCULLY WILLIAM P 10%+ Owner Oct 13, 2026 | BUY | $835.5K |
SCULLY WILLIAM P 10%+ Owner Oct 8, 2026 | BUY | $770.9K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.53 | $0.30–$0.75 | -29.1% | $19.9M |
| Next Q | -$0.36 | -$0.36–-$0.36 | +12.2% | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | -$1.24 | -$1.37–-$1.11 | +18.4% | $21.0M |
Short side
FINRA· Oct 30, 2026SecBot reports
20 filings · 11 bullish · 1 bearish · 8 neutral- NEUTRAL 3Nov 13, 2026
Todd W. Fennell filed a Form 3 initial statement of beneficial ownership, indicating he has become…
Monitor future Form 4 filings for any insider purchases or grants that may signal conviction. The zero-share initial filing is typical for a new director or officer with no prior equity stake.
- NEUTRAL SC 13G/ANov 13, 2026
William P. Scully filed an amended Schedule 13G disclosing beneficial ownership of 6,404,846…
Monitor for any future conversion to Schedule 13D if Scully's investment approach shifts from passive to activist. The stake is large enough to influence governance if the holder becomes active.
- BULLISH INSIDER-BUYNov 10, 2026
10% owner William Scully purchased $1.19M of PRTA stock in an open-market transaction…
Monitor for further insider buying or any material corporate developments (e.g., clinical trial updates, partnership news) that may have prompted this conviction purchase. The sustained insider…
- NEUTRAL 8-KNov 5, 2026
Prothena reported Q3 2026 financial results with a net loss of $16.5M, improved from a $36.5M loss…
Watch for the moponetug Phase 2 data readout in 1H 2027 as the next major binary catalyst. The company's cash runway appears sufficient to fund operations through key milestones without near-term…
All PRTA filing & press-release reports (20)
- 3 reportNov 13, 2026
- SC 13G/A reportNov 13, 2026
- INSIDER-BUY reportNov 10, 2026
- 8-K reportNov 5, 2026
- 8-K reportOct 29, 2026
- INSIDER-BUY reportOct 26, 2026
- INSIDER-BUY reportOct 15, 2026
- INSIDER-BUY reportSep 30, 2026
- INSIDER-BUY reportSep 29, 2026
- INSIDER-BUY reportSep 21, 2026
- INSIDER-BUY reportSep 3, 2026
- INSIDER-BUY reportAug 21, 2026
- INSIDER-BUY reportAug 10, 2026
- CLUSTER reportJul 30, 2026
- INSIDER-BUY reportJun 18, 2026
- INSIDER-BUY reportJun 12, 2026
- 3 reportMay 14, 2026
- 8-K reportMay 7, 2026
- DEFA14A reportMar 27, 2026
- EFFECT reportMar 3, 2026